Which Is Preferable for Chronic Limb-threatening Ischemia: Bypass versus Endovascular Therapy?
M, H., K, Y., & MB, M. (2026). Which Is Preferable for Chronic Limb-threatening Ischemia: Bypass versus Endovascular Therapy?. Advances in surgery. https://doi.org/10.1016/j.yasu.2026.03.003
M H, K Y, MB M. Which Is Preferable for Chronic Limb-threatening Ischemia: Bypass versus Endovascular Therapy?. Advances in surgery. 2026; doi: 10.1016/j.yasu.2026.03.003
M H, K Y, MB M. Which Is Preferable for Chronic Limb-threatening Ischemia: Bypass versus Endovascular Therapy?[J]. Advances in surgery. 2026. DOI: 10.1016/j.yasu.2026.03.003.
@article{m2026,
author = {Hamouda M and Yei K and Malas MB},
title = {Which Is Preferable for Chronic Limb-threatening Ischemia: Bypass versus Endovascular Therapy?},
journal = {Advances in surgery},
year = {2026},
doi = {10.1016/j.yasu.2026.03.003},
note = {PMID: 42556959},
}
TY - JOUR AU - Hamouda M AU - Yei K AU - Malas MB TI - Which Is Preferable for Chronic Limb-threatening Ischemia: Bypass versus Endovascular Therapy? T2 - Advances in surgery PY - 2026 DO - 10.1016/j.yasu.2026.03.003 AN - PMID:42556959 ER -
Chronic limb-threatening ischemia is the most advanced stage of peripheral arterial disease and typically requires revascularization to prevent limb-loss. The choice of open surgical bypass versus endovascular therapy should be individualized based on patients' anatomy, operative risk, and conduit availability. Patients who are suitable candidates for both bypass and endovascular intervention and have an adequate single-segment great saphenous vein should undergo open surgical bypass based on level 1 evidence.